Genmab | Capitale Ordinario



Ordinary Share Capital Cambiamento Data
Agios Pharmaceuticals USD 73K 0 2024-12
Almirall EUR 25.62M 489K 2024-06
Amarin USD 305.2M 156K 2024-09
Amgen USD 33.53B 140M 2024-12
AstraZeneca USD 388M 0 2024-12
Bayer EUR 2.52B 0 2024-12
BioMarin Pharmaceutical USD 191K 0 2024-12
Demant DKK 44M 1000K 2024-12
Exelixis USD 282K 4K 2025-01
Fresenius Medical Care EUR 293.41M 0 2024-12
Galapagos EUR 293.94M 0 2024-12
Genmab DKK 66M 0 2024-12
GlaxoSmithKline GBP 1.35B 0 2024-12
GN Store Nord DKK 604M 0 2024-12
GRIFOLS EUR 119.6M 0 2024-12
Hikma Pharmaceutical USD 40M 0 2024-06
Insmed USD 1.79M 6K 2024-12
Lonza CHF 72M 0 2024-12
Merck EUR 168M 397M 2024-12
Novartis USD 793M 0 2024-12
Regeneron Pharmaceuticals USD 100K 2K 2024-09
Roche Holding CHF 107M 0 2024-06
UCB EUR 189.72 584M 2024-06



Genmab Capitale Ordinario - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Apr 2025.